Immuno-Modulation to Treat Common Cardiovascular Diseases: Moving From Sledgehammer to Precision Therapeutics
- PMID: 35177193
- DOI: 10.1016/j.jacc.2021.12.007
Immuno-Modulation to Treat Common Cardiovascular Diseases: Moving From Sledgehammer to Precision Therapeutics
Keywords: B lymphocytes; hypoxia-inducible factor; microRNA 21; myocardial infarction.
Conflict of interest statement
Funding Support and Author Disclosures Dr Kovacic has received support from the National Institutes of Health (R01HL130423, R01HL135093, and R01HL148167-01A1), New South Wales Health grant RG194194, and the Bourne Foundation. Dr Boscá has received support from MICIN/AEI/10.13039/501100011033 (PID2020-113238RB-I00), ISCIII-CIBERCV (CB16/11/00222) and Comunidad de Madrid, S2017/BMD-3686, and FSE/FEDER.
Comment on
-
Splenic Marginal Zone B Lymphocytes Regulate Cardiac Remodeling After Acute Myocardial Infarction in Mice.J Am Coll Cardiol. 2022 Feb 22;79(7):632-647. doi: 10.1016/j.jacc.2021.11.051. J Am Coll Cardiol. 2022. PMID: 35177192
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
